Adjuvant SOX chemotherapy versus concurrent chemoradiotherapy after D2 radical resection of locally advanced esophagogastric junction (EGJ) adenocarcinoma: study protocol for a randomized phase III trial (ARTEG)

被引：0
|
作者：
Jinwen Shen
Xiu Zhu
Yian Du
Yuan Zhu
Pengfei Yu
Litao Yang
Zhiyuan Xu
Ling Huang
Yunli Zhang
Yanqiang Zhang
Luying Liu
Xiangdong Cheng
机构：
[1] Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital),Department of Abdominal Radiotherapy
[2] Zhejiang Provincial Research Center for Cancer of Upper Gastrointestinal Tract,Department of Pathology
[3] Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital),Department of Abdominal Surgery
[4] Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital),undefined
来源：
Trials | / 22卷
关键词：
Esophagogastric junction adenocarcinoma; D2 radical resection; Adjuvant chemoradiotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Re: Adjuvant Sandwich Chemotherapy plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer after Radical Cystectomy: A Randomized Phase 2 Trial Editorial Comment
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2019, 201 (01): : 29 - 29
  • [32] RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction-a randomized phase III joint study of the AIO, ARO and DGAV
    Lorenzen, Sylvie
    Biederstaedt, Alexander
    Ronellenfitsch, Ulrich
    Reissfelder, Christoph
    Moenig, Stefan
    Wenz, Frederik
    Pauligk, Claudia
    Walker, Martin
    Al-Batran, Salah-Eddin
    Haller, Bernhard
    Hofheinz, Ralf-Dieter
    BMC CANCER, 2020, 20 (01)
  • [33] Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial
    Jie Shen
    Beibei Cao
    Yatao Wang
    Aitang Xiao
    Jichao Qin
    Jianhong Wu
    Qun Yan
    Yuanlong Hu
    Chuanyong Yang
    Zhixin Cao
    Junbo Hu
    Ping Yin
    Daxing Xie
    Jianping Gong
    Trials, 19
  • [34] A two centers study of postoperative adjuvant chemotherapy with S-1 versus SOX/XELOX regimens for gastric cancer after D2 resection: a cohort study
    Zheng, Song
    Zhou, Yao
    Sun, Yangcheng
    Wang, Zhen
    Lu, Yidan
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (04) : 819 - 827
  • [35] A two centers study of postoperative adjuvant chemotherapy with S-1 versus SOX/XELOX regimens for gastric cancer after D2 resection: a cohort study
    Song Zheng
    Yao Zhou
    Yangcheng Sun
    Zhen Wang
    Yidan Lu
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 819 - 827
  • [36] Efficacy and Safety of Sintilimab in Combination with Concurrent Chemoradiotherapy for Locally Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (SHARED): Study Protocol of a Prospective, Multi-Center, Single-Arm Phase 2 Trial
    Wei, Jia
    Lu, Xiaofeng
    Liu, Qin
    Fu, Yao
    Liu, Song
    Li, Lin
    Liu, Fangcen
    Fan, Xiangshan
    Yang, Ju
    Yang, Yang
    Zhao, Yang
    Guan, Wenxian
    Liu, Baorui
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 2007 - 2015
  • [37] Randomized trial of adjuvant chemotherapy versus concurrent chemoradiotherapy in early-stage cervical cancer after radical surgery: A Chinese Gynecologic Oncology Group study (CSEM-002)
    Weng, D.
    Wang, H.
    Zhu, C.
    Cui, B.
    Wang, C.
    Li, K.
    Gao, Q.
    Cheng, X.
    Yang, X.
    Jiang, J.
    Zhang, Y.
    Kong, B.
    Xie, X.
    Ma, D.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 30 - 30
  • [38] Randomized phase II trial of upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy versus preoperative chemoradiotherapy followed by surgery and adjuvant chemotherapy in locally advanced rectal cancer: KCSG-CO14-10
    Beom, S-H.
    Park, S. H.
    Ahn, J. B.
    Kim, H. S.
    Shin, S. J.
    Lee, K. Y.
    Min, B. S.
    Kim, N. K.
    Kim, T.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S726 - S726
  • [39] Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2+CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial
    Shen, Jie
    Cao, Beibei
    Wang, Yatao
    Xiao, Aitang
    Qin, Jichao
    Wu, Jianhong
    Yan, Qun
    Hu, Yuanlong
    Yang, Chuanyong
    Cao, Zhixin
    Hu, Junbo
    Yin, Ping
    Xie, Daxing
    Gong, Jianping
    TRIALS, 2018, 19
  • [40] PILGRIM: Phase III clinical trial in evaluating the role of hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer patients after radical gastrectomy with D2 lymphadenectomy(HIPEC-01).
    Cui, Shu-zhong
    Liang, Han
    Li, Yong
    Zhou, Yanbing
    Tao, Kaixiong
    Zhou, Zhiwei
    Li, Guoxin
    Li, Peiyu
    Zhou, Baojun
    Yao, Hongliang
    Peng, Zheng
    Xiong, Bin
    Pang, Minghui
    Cai, Shirong
    Wan, Jin
    Liang, Bin
    Lei, Ziying
    Wang, Jiping
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345